Vermeire S - Search Results

1

A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis.

Arias MT, Vande Casteele N, Vermeire S, de Buck van Overstraeten A, Billiet T, Baert F, Wolthuis A, Van Assche G, Noman M, Hoffman I, D'Hoore A, Gils A, Rutgeerts P, Ferrante M. Arias MT, et al. Among authors: vermeire s. Clin Gastroenterol Hepatol. 2015 Mar;13(3):531-8. doi: 10.1016/j.cgh.2014.07.055. Epub 2014 Aug 10. Clin Gastroenterol Hepatol. 2015. PMID: 25117777

2

Clustering of increased small intestinal permeability in families with Crohn's disease.

Peeters M, Geypens B, Claus D, Nevens H, Ghoos Y, Verbeke G, Baert F, Vermeire S, Vlietinck R, Rutgeerts P. Peeters M, et al. Among authors: vermeire s. Gastroenterology. 1997 Sep;113(3):802-7. doi: 10.1016/s0016-5085(97)70174-4. Gastroenterology. 1997. PMID: 9287971

3

[Drug prevention of Crohn disease recurrence in the neo-terminal ileum after ileocolic resection].

Vermeire S, Rutgeerts P. Vermeire S, et al. Zentralbl Chir. 1998;123(4):352-6. Zentralbl Chir. 1998. PMID: 9622893 Review. German.

4

Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease.

Rutgeerts P, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Gastroenterology. 1998 Oct;115(4):1006-9. doi: 10.1016/s0016-5085(98)70274-4. Gastroenterology. 1998. PMID: 9786723 Review. No abstract available.

5

Diagnostic approach to IBD.

Vermeire S, Peeters M, Rutgeerts P. Vermeire S, et al. Hepatogastroenterology. 2000 Jan-Feb;47(31):44-8. Hepatogastroenterology. 2000. PMID: 10690584 Review.

6

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.

Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, Jewell D, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2000 Aug;6(3):165-70. doi: 10.1097/00054725-200008000-00002. Inflamm Bowel Dis. 2000. PMID: 10961588

7

Serological diagnosis of inflammatory bowel disease.

Rutgeerts P, Vermeire S. Rutgeerts P, et al. Among authors: vermeire s. Lancet. 2000 Dec 23-30;356(9248):2117-8. doi: 10.1016/s0140-6736(00)03488-7. Lancet. 2000. PMID: 11191535 No abstract available.

8

Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease.

Vermeire S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, Groenen P, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):827-33. doi: 10.1053/gast.2001.22546. Gastroenterology. 2001. PMID: 11231936

9

Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.

Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):834-40. doi: 10.1053/gast.2001.22453. Gastroenterology. 2001. PMID: 11231937

10

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2001 Feb;7(1):8-15. doi: 10.1097/00054725-200102000-00002. Inflamm Bowel Dis. 2001. PMID: 11233666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

891 results

Search Page

Filters